Concepedia

M. Nagamani

MN

3

Publications

77

Citations

3

H-Index

2016

Active since

Affiliations

Osmania University(Current)

M. Nagamani is an author at Osmania University specializing in drug discovery, medicinal chemistry, and radiation oncology.

Top concepts

MedicineMicrobiologyPharmacologyDrug DiscoveryOrganic ChemistryRadiation OncologyMedicinal Chemistry

Publications per year

2016–2022

3

Publications

3

Design, synthesis and anticancer activity of 5-((2-(4-bromo/chloro benzoyl) benzofuran-5-yl) methyl)-2-((1-(substituted)-1H-1,2,3-triazol-4-yl)methoxy)benzaldehyde analogues

M. Veerabhadraiah, V. Krishna Chaitanya, M. Nagamani · Molecular Diversity · 2022 · 35 citations

Medicinal Chemistry, 4-Bromo/chloro Benzoyl, Derivative (Chemistry) +11

Molecular docking studies on COVID-19 and antibacterial evaluation of newly synthesized 4-(methoxymethyl)-1,2,3-triazolean analogues derived from (E)-1-phenyl-3-(2-(piperidin-1-yl)quinolin-3-yl) prop-2-en-1-one

M. Nagamani, Medidi Srinivas · Journal of the Iranian Chemical Society · 2021 · 23 citations · Full text

Synthesis, anti-microbial activity, and cytotoxicity of novel 1-[5-[6-[(2-benzoylbenzofuran-5-yl)methyl]-2-oxo-2H-chromen-3-yl]thiazol-2-yl]urea derivatives

B. Shankar, Jalapathi Pochampally, M. Nagamani et al. · Monatshefte für Chemie - Chemical Monthly · 2016 · 19 citations

Anti-microbial Activity, Microbiology, Antimicrobial Compound

Rows per page

1–3 of 3